NuCana PLC NCNA

Healthcare Biotechnology

NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-3373, and NUC-7738. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). 5-FU is a prescribed anti-cancer agent. NUC-3373 has been evaluated in a Phase I clinical trial for patients with advanced solid tumors and is under Phase Ib/II clinical trial for patients with advanced colorectal cancer. NUC-7738 is a ProTide transformation of a nucleoside analog, 3’-deoxyadenosine (3’-Da). The Company is evaluating NUC-7738 in a Phase I/II clinical trial for patients with advanced solid tumors. Its pipeline also includes Acelari, which is a ProTide transformation of the nucleoside analog gemcitabine. The Company’s subsidiaries include NuCana, Inc., NuCana Limited and NuCana BioMed Trustee Company Limited.

NDAQ:NCNA - Post by User

NuCana PLC

<< Previous

Bullboard Posts

Post by whytestockson Apr 16, 2024 10:15am

19 Views

Post# 35991383

US Companies Moving the Markets, Morning edition <br>Tue, Ap

Just In: $NCNA US Companies Moving the Markets, Morning edition <br>Tue, Apr 16, 2024 as of 10.00 am ETA look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 37.1% to $0.1629 on volume of 102,747,129 shares WiSA Technologies Inc. (WISA) rose 69.1% to $2.96 on volume of 24,734,833 shares Peraso Inc. (PRSO) rose 37.0% to $1.7393 on volume of 23,546,162 shares ...NCNA - US Companies Moving the Markets, Morning edition <br>Tue, Apr 16, 2024 as of 10.00 am ET

<< Previous

Bullboard Posts

How a world class helium discovery in Minnesota was made by chance